Procurement Summary
Country: Brazil
Summary: Price Record for Contraceptives and other Hormones. Note: in Case of Discrepancy between the Description in Annex Ii and that of the Purchasing System, the Provisions in Annex Ii of the Notice will Prevail.
Deadline: 09 Jun 2026
Posting Date: 25 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 141998003
Document Ref. No.: 90099/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Object: Electronic Auction - Price Record for contraceptives and other hormones. NOTE: In case of discrepancy between the description in Annex II and that of the Purchasing System, the provisions in Annex II of the Notice will prevail. UASG code: 986291 Notice from: 05/25/2026 from 08:00 to 17:59 Proposal Delivery: from 05/25/2026 at 08:00 ETONOGESTREL, CONCENTRATION 68 MG, PHARMACEUTICAL FORM SUBDERMAL IMPLANT Quantity: 8325 NORETISTERONE, CONCENTRATION 0.35 MG, ADDITIONAL CHARACTERISTICS IN BLISTER CALENDAR Quantity: 2550 LEVONORGESTREL, DOSAGE 0.75 MG Quantity: 15 MEDROXIPROGESTERONE ACETATE, COMPOSITION ASSOCIATED WITH ESTRADIOL CYPIONATE, CONCENTRATION 50 MG + 10 MG/ML, PHARMACEUTICAL FORM INJECTABLE SUSPENSION Quantity: 860 MEDROXYPROGESTERONE ACETATE, DOSAGE 10 MG Quantity: 75 PROGESTERONE, DOSAGE 200 MG Quantity: 4665 ALGESTONE ACETOPHENIDE, ACTIVE INGREDIENT ASSOCIATED WITH ESTRADIOL ENANTATE, DOSAGE 150 MG + 10 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 3600 LEVONORGESTREL, COMPOSITION ASSOCIATED WITH ETHINYLESTRADIOL, CONCENTRATION 0.15 MG + 0.03 MG, ADDITIONAL CHARACTERISTICS IN CALENDAR BLISTER Quantity: 20775 LEVONORGESTREL, COMPOSITION ASSOCIATED WITH ETHINYLESTRADIOL, CONCENTRATION 0.15 MG + 0.03 MG, ADDITIONAL CHARACTERISTICS IN CALENDAR BLISTER Quantity: 6925 ESTRADIOL, VALERATE PRESENTATION ASSOCIATED WITH NORETISTERONE ENANTATE, DOSAGE 5MG + 50MG/1ML, INJECTABLE USE Quantity: 60375 ESTRADIOL, VALERATE PRESENTATION ASSOCIATED WITH NORETISTERONE ENANTHATE, DOSAGE 5MG + 50MG/1ML, INJECTABLE USE Quantity: 20125 MEDROXIPROGESTERONE ACETATE, CONCENTRATION 150 MG/ML, PHARMACEUTICAL FORM INJECTABLE SUSPENSION Quantity: 552 MEDROXIPROGESTERONE ACETATE, CONCENTRATION 150 MG/ML, PHARMACEUTICAL FORM INJECTABLE SUSPENSION Quantity: 183 LEVONORGESTREL, CONCENTRATION 52 MG, ADDITIONAL CHARACTERISTICS INTRA-UTERAL SYSTEM...
Documents
Tender Notice